Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sustained Virological Response”

Showing 20 of 0 results

Not applicableStudy completedNCT02582671
What this trial is testing

The Effectiveness of ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland

Who this might be right for
Chronic Hepatitis C
AbbVie 101
Not applicableStudy completedNCT02817594
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 51
Not applicableStudy completedNCT03566966
What this trial is testing

Autoantibodies and Direct-acting Antivirals

Who this might be right for
Viral Hepatitis CTherapy Adverse Effect
University of Bari 191
Large-scale testing (Phase 3)Study completedNCT01542788
What this trial is testing

Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 278
Not applicableEnded earlyNCT02292706
What this trial is testing

A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 1,609
Not applicableWithdrawnNCT00704756
What this trial is testing

An Observational Study of Patients With Chronic Hepatitis C Undergoing Treatment With PegIntron and Rebetol in Clinical Practice in Belgium (Study P05494)(WITHDRAWN)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT02103699
What this trial is testing

Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir

Who this might be right for
Hepatitis C Virus
Janssen Scientific Affairs, LLC 315
Not applicableUnknownNCT01151397
What this trial is testing

Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients?

Who this might be right for
Chronic Hepatitis C
Ziv Hospital 60
Not applicableStudy completedNCT01457768
What this trial is testing

A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 570
Not applicableStudy completedNCT01457755
What this trial is testing

Gilead Sustained Virologic Response (SVR) Registry

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 6,625
Large-scale testing (Phase 3)Study completedNCT02753699
What this trial is testing

Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients

Who this might be right for
Hepatitis C
Debiopharm International SA 723
Not applicableStudy completedNCT04719338
What this trial is testing

Occult HCV Infection After DAAD Treatment in Haemodialysis Patients

Who this might be right for
Hepatitis C
Alexandria University 30
Post-approval studies (Phase 4)Study completedNCT02601976
What this trial is testing

Evaluation of Unipeg® for Response and Ongoing Safety in Pakistani Population

Who this might be right for
Hepatitis C
Getz Pharma 64
Testing effectiveness (Phase 2)Study completedNCT01271790
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 245
Testing effectiveness (Phase 2)Study completedNCT00901524
What this trial is testing

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV

Who this might be right for
Hepatitis
ANRS, Emerging Infectious Diseases 58
Not applicableStudy completedNCT01750216
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 196
Testing effectiveness (Phase 2)Study completedNCT04676724
What this trial is testing

Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B
GlaxoSmithKline 108
Testing effectiveness (Phase 2)Study completedNCT01984294
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Infection

Who this might be right for
Chronic HCV Infection
Gilead Sciences 101
Not applicableUnknownNCT05170490
What this trial is testing

Long Term Follow up of Chronic HCV Patients Receiving DAAS

Who this might be right for
Chronic Hepatitis c
Sohag University 100
Testing effectiveness (Phase 2)Study completedNCT01808248
What this trial is testing

Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3

Who this might be right for
Hepatitis C
Gilead Sciences 47
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation